Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Boston Scientific Corporation
With
The Primary Endpoint of this study is Tumour resectability at surgery. Secondary Endpoints: 1. Safety assessed by SAE and AE monitoring (NCI CTCAE v3.0) 2. Tumour response assessed by imaging (RECIST and necrosis) 3. Viable residual tumour assessed by pathological evaluation of resected liver tissue. 4. Recurrence (time and site) following resection 5. Correlation of tumour response by imaging and pathology
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted